Sutro Biopharma
STRO
STRO
113 hedge funds and large institutions have $40M invested in Sutro Biopharma in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 32 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 123 → 113 (-10)
33% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 27
66% less capital invested
Capital invested by funds: $118M → $40M (-$77.6M)
Holders
113
Holding in Top 10
2
Calls
$35K
Puts
$27K
Top Buyers
| 1 | +$2.89M | |
| 2 | +$1.17M | |
| 3 | +$1.04M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$899K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$785K |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$3.97M | |
| 3 | -$3.18M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.58M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.51M |
